
AIM vs GRML
$AIM vs $GRML head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
AIM vs GRML: the quick read
- ·GRML is the larger company by market cap ($73M vs $5M).
- ·GRML has been more active on our scanner (343 vs 14 alerts in 30 days).
- ·GRML has the smaller float (13.3M vs 28.4M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·AIM trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·GRML draws far more of our scanner's attention, 343 unusual-volume alerts in 30 days against 14, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: GRML is more than 14x the market cap of AIM, so the same dollar of news moves AIM far harder.
- ·They are pulling apart today: AIM is outperforming the other by roughly 6.7 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing AIM and GRML on TheDesperateTrader.
- Is AIM or GRML the better stock?
- "Better" depends on your goal, and these two are not alike. GRML is the larger company by market cap ($73M vs $5M). GRML has been more active on our scanner (343 vs 14 alerts in 30 days). GRML has the smaller float (13.3M vs 28.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between AIM and GRML?
- The differences that matter: they are not in the same business - AIM is biological products, (no diagnostic substances) and GRML is biological products, (no diagnostic substances); GRML is roughly 14x the size of the other by market cap ($5M vs $73M); they trade at very different share prices ($0.17 vs $5.19); AIM sits at 1% of its 52-week range against 28% for GRML; our scanner flagged AIM 14 times in the last 30 days against 343 for GRML. Everything above is measured from the latest completed session and SEC filings.
- Which of AIM and GRML is more active right now?
- Right now AIM is at about 0.2x its normal volume and GRML is at about 0.1x, so AIM is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading AIM or GRML? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore AIM and GRML comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.